Raftace (180 ml) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Merind Ltd (Wockhardt Ltd). This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Magnesium Trisilicate, Dried Aluminium Hydroxide,Sodium Alginate. This drug comes in the form of Syrup. The general packing available for this medicine consists of 180 ml and is priced at Rs 29.5 (arround $0.413 US Dollar)
The main active ingredients or salts in Raftace (180 ml) are :
Magnesium Trisilicate-125 mg
Dried Aluminium Hydroxide-300 mg
Sodium Alginate-200 mg
Magnesium Trisilicate Indication (Prescribed for or used as): Antacid in the treatment of peptic ulcer. Ciprofloxacin over dose or toxicity.
For more details on Magnesium Trisilicate, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Magnesium Trisilicate..
Dried Aluminium Hydroxide Indication (Prescribed for or used as):
For more details on Dried Aluminium Hydroxide, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Dried Aluminium Hydroxide..
Sodium Alginate Indication (Prescribed for or used as): Heart burn. Gastrooesophageal reflux diseases.
For more details on Sodium Alginate, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Sodium Alginate..
Raftace (180 ml) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 3 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Raftace (180 ml), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Magnesium Trisilicate-125 mg Dried Aluminium Hydroxide-300 mg Sodium Alginate-200 mg). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.
Raftace (180 ml) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Merind Ltd (Wockhardt Ltd). This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Dried Aluminium Hydroxide, Magnesium Trisilicate,Sodium Alginate. This drug comes in the form of Syrup. The general packing available for this medicine consists of 180 ml and is priced at Rs 29.5 (arround $0.413 US Dollar)
The main active ingredients or salts in Raftace (180 ml) are :
Dried Aluminium Hydroxide-300 mg
Sodium Alginate-200 mg
Magnesium Trisilicate-125 mg
Dried Aluminium Hydroxide Indication (Prescribed for or used as):
For more details on Dried Aluminium Hydroxide, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Dried Aluminium Hydroxide..
Magnesium Trisilicate Indication (Prescribed for or used as): Antacid in the treatment of peptic ulcer. Ciprofloxacin over dose or toxicity.
For more details on Magnesium Trisilicate, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Magnesium Trisilicate..
Sodium Alginate Indication (Prescribed for or used as): Heart burn. Gastrooesophageal reflux diseases.
For more details on Sodium Alginate, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Sodium Alginate..
Raftace (180 ml) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 0 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Raftace (180 ml), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Dried Aluminium Hydroxide-300 mg Sodium Alginate-200 mg Magnesium Trisilicate-125 mg). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.